Building the Capacity in Local Communities of Developing Countries to Achieve SDG3: Strengthening Treatment Capacity for Structural Heart Diseases using Percutaneous and Non-fluoroscopic Procedures in Developing Countries
Reference
PDF-SDG-2023-01
Implementing Entity/ies
UNDESA
Collaborating Partners
WHO, National Health Commission of China
Duration
March 2024 – March 2026
Location
Bangladesh, Cambodia, Lao People’s Democratic Republic, Tanzania, Türkiye, Uzbekistan
Approved Budget
$ 1,199,986
Description
Cardiovascular diseases (CVDs), including structural heart diseases, are a leading cause of mortality worldwide. However, treatment for these diseases is often limited in underdeveloped countries due to the requirement for advanced medical equipment and facilities. To address this challenge, the Percutaneous and Non-fluoroscopic procedure (PAN) was developed by Dr. Pan Xiangbin and the heart disease treatment team at Fuwai Hospital, Chinese Academy of Medical Sciences. PAN is a novel surgical method that enables the treatment of common cardiovascular diseases without the need for a catheter lab or exposure to harmful radiation. It improves access to and reduces the cost of cardiovascular care for many poor patients who cannot afford it, especially in low- and middle-income countries. Recognizing its impact, the PAN was awarded as one of the innovative solutions for health challenges by the WHO West Pacific in 2022.
The project aims to enhance access to CVD treatment in developing countries by strengthening their capacity in utilizing the PAN Procedure. By introducing and promoting the PAN Procedure, the project seeks to improve the quality of treatment for structural heart diseases, elevate the medical skills and knowledge of healthcare professionals in these countries, and establish collaborative networks among various stakeholders, including local medical institutions, healthcare systems, and international organizations.
The project aims to enhance access to CVD treatment in developing countries by strengthening their capacity in utilizing the PAN Procedure. By introducing and promoting the PAN Procedure, the project seeks to improve the quality of treatment for structural heart diseases, elevate the medical skills and knowledge of healthcare professionals in these countries, and establish collaborative networks among various stakeholders, including local medical institutions, healthcare systems, and international organizations.